Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2021 Sep 28

PMID 34572346

Citations 16

Authors

Chien-Hsiu Li

Yu-Chan Chang

Ming-Hsien Chan

Yi-Fang Yang

Shu-Mei Liang

Michael Hsiao

Affiliations

Soon will be listed here.

Abstract

Changes in cell growth and metabolism are affected by the surrounding environmental factors to adapt to the cell's most appropriate growth model. However, abnormal cell metabolism is correlated with the occurrence of many diseases and is accompanied by changes in galectin (Gal) performance. Gals were found to be some of the master regulators of cell-cell interactions that reconstruct the microenvironment, and disordered expression of Gals is associated with multiple human metabolic-related diseases including cancer development. Cancer cells can interact with surrounding cells through Gals to create more suitable conditions that promote cancer cell aggressiveness. In this review, we organize the current understanding of Gals in a systematic way to dissect Gals' effect on human disease, including how Gals' dysregulated expression affects the tumor microenvironment's metabolism and elucidating the mechanisms involved in Gal-mediated diseases. This information may shed light on a more precise understanding of how Gals regulate cell biology and facilitate the development of more effective therapeutic strategies for cancer treatment by targeting the Gal family.

Citing Articles

Lung cancer exosomal Gal3BP promotes osteoclastogenesis with potential connotation in osteolytic metastasis.

Ghanta P, Hessel E, Arias-Alvarado A, Aghayev M, Ilchenko S, Kasumov T Sci Rep. 2024; 14(1):27201.

PMID: 39516568 PMC: 11549321. DOI: 10.1038/s41598-024-79006-w.

Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance.

Kim H, Kretz L, Ronin C, Starck C, Roper J, Kahl-Knutson B Int J Mol Sci. 2024; 25(12).

PMID: 38928409 PMC: 11203799. DOI: 10.3390/ijms25126704.

Hspb1 and Lgals3 in spinal neurons are closely associated with autophagy following excitotoxicity based on machine learning algorithms.

Yan L, Li Z, Li C, Chen J, Zhou X, Cui J PLoS One. 2024; 19(5):e0303235.

PMID: 38728287 PMC: 11086895. DOI: 10.1371/journal.pone.0303235.

Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis.

Perez-Moreno E, Oyanadel C, de la Pena A, Hernandez R, Perez-Molina F, Metz C Biol Res. 2024; 57(1):14.

PMID: 38570874 PMC: 10993482. DOI: 10.1186/s40659-024-00490-5.

Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma.

Matoba Y, Zarrella D, Pooladanda V, Azimi Mohammadabadi M, Kim E, Kumar S Br J Cancer. 2024; 130(9):1463-1476.

PMID: 38438589 PMC: 11058234. DOI: 10.1038/s41416-024-02621-x.

References

Liang Z, Wu B, Ji Z, Liu W, Shi D, Chen X . The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells. Cancer Lett. 2021; 513:90-100. DOI: 10.1016/j.canlet.2021.05.003. View

Menon S, Kang C, Beningo K . Galectin-3 secretion and tyrosine phosphorylation is dependent on the calpain small subunit, Calpain 4. Biochem Biophys Res Commun. 2011; 410(1):91-6. PMC: 3124573. DOI: 10.1016/j.bbrc.2011.05.112. View

Sun W, Li L, Li L, Yang Q, Zhang Z, Huang Y . Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12. Acta Pharmacol Sin. 2017; 38(6):806-822. PMC: 5520179. DOI: 10.1038/aps.2016.137. View

Petrovic I, Pejnovic N, Ljujic B, Pavlovic S, Kovacevic M, Jeftic I . Overexpression of Galectin 3 in Pancreatic β Cells Amplifies β-Cell Apoptosis and Islet Inflammation in Type-2 Diabetes in Mice. Front Endocrinol (Lausanne). 2020; 11:30. PMC: 7018709. DOI: 10.3389/fendo.2020.00030. View

Tan S, Krasnow M . Developmental origin of lung macrophage diversity. Development. 2016; 143(8):1318-27. PMC: 4852511. DOI: 10.1242/dev.129122. View

Zhang P, Sun Y, Peng R, Chen W, Fu X, Zhang L . Long non-coding RNA Rpph1 promotes inflammation and proliferation of mesangial cells in diabetic nephropathy via an interaction with Gal-3. Cell Death Dis. 2019; 10(7):526. PMC: 6614467. DOI: 10.1038/s41419-019-1765-0. View

Demotte N, Wieers G, Van Der Smissen P, Moser M, Schmidt C, Thielemans K . A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice. Cancer Res. 2010; 70(19):7476-88. DOI: 10.1158/0008-5472.CAN-10-0761. View

Sun J, Zhang L, Fang J, Yang S, Chen L . Galectin-3 mediates high-glucose-induced cardiomyocyte injury by the NADPH oxidase/reactive oxygen species pathway. Can J Physiol Pharmacol. 2020; 98(11):826-833. DOI: 10.1139/cjpp-2019-0708. View

Astorgues-Xerri L, Riveiro M, Tijeras-Raballand A, Serova M, Rabinovich G, Bieche I . OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis. Eur J Cancer. 2014; 50(14):2463-77. DOI: 10.1016/j.ejca.2014.06.015. View

10.

Li S, Li S, Hao X, Zhang Y, Deng W . Perindopril and a Galectin-3 Inhibitor Improve Ischemic Heart Failure in Rabbits by Reducing Gal-3 Expression and Myocardial Fibrosis. Front Physiol. 2019; 10:267. PMC: 6438875. DOI: 10.3389/fphys.2019.00267. View

11.

Limagne E, Richard C, Thibaudin M, Fumet J, Truntzer C, Lagrange A . Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients. Oncoimmunology. 2019; 8(4):e1564505. PMC: 6422400. DOI: 10.1080/2162402X.2018.1564505. View

12.

Vasta G . Galectins as pattern recognition receptors: structure, function, and evolution. Adv Exp Med Biol. 2011; 946:21-36. PMC: 3429938. DOI: 10.1007/978-1-4614-0106-3_2. View

13.

Jin M, Jin W . The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020; 5(1):166. PMC: 7447642. DOI: 10.1038/s41392-020-00280-x. View

14.

Streetly M, Maharaj L, Joel S, Schey S, Gribben J, Cotter F . GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death. Blood. 2010; 115(19):3939-48. PMC: 5292593. DOI: 10.1182/blood-2009-10-251660. View

15.

Demotte N, Bigirimana R, Wieers G, Stroobant V, Squifflet J, Carrasco J . A short treatment with galactomannan GM-CT-01 corrects the functions of freshly isolated human tumor-infiltrating lymphocytes. Clin Cancer Res. 2014; 20(7):1823-33. DOI: 10.1158/1078-0432.CCR-13-2459. View

16.

Hossein G, Halvaei S, Heidarian Y, Dehghani-Ghobadi Z, Hassani M, Hosseini H . Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids. Cancer Med. 2019; 8(9):4315-4329. PMC: 6675724. DOI: 10.1002/cam4.2334. View

17.

Krishnan V, Bane S, Kawle P, Naresh K, Kalraiya R . Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin Exp Metastasis. 2005; 22(1):11-24. DOI: 10.1007/s10585-005-2036-2. View

18.

Cristiani C, Turdo A, Ventura V, Apuzzo T, Capone M, Madonna G . Accumulation of Circulating CCR7 Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway. Cancer Immunol Res. 2019; 7(5):841-852. DOI: 10.1158/2326-6066.CIR-18-0651. View

19.

Yoneshima Y, Iwama E, Matsumoto S, Matsubara T, Tagawa T, Ota K . Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis. Sci Rep. 2021; 11(1):12732. PMC: 8211684. DOI: 10.1038/s41598-021-92098-y. View

20.

Wang D, You D, Li L . Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function. J Toxicol Sci. 2019; 44(1):47-56. DOI: 10.2131/jts.44.47. View